Thiamine Deficiency in Children: Dosing and Management
For children with suspected or confirmed thiamine deficiency, administer 100 mg IV daily for at least 3-4 days, with higher doses (200-300 mg IV daily) for severe presentations including encephalopathy, cardiac involvement, or lactic acidosis. 1, 2
Clinical Context and Severity-Based Approach
Thiamine deficiency in children can rapidly progress to life-threatening complications including Wernicke's encephalopathy, severe lactic acidosis, cardiomyopathy, and death within days to weeks if untreated 3, 4. The key is recognizing that thiamine reserves deplete within 20 days of inadequate intake, making early aggressive treatment critical 1.
Dosing by Clinical Severity
For Acute/Severe Deficiency (encephalopathy, cardiac symptoms, lactic acidosis):
- 100-300 mg IV daily for 3-4 days minimum 1, 5
- In life-threatening presentations (Wernicke's encephalopathy, severe lactic acidosis): consider 200-300 mg IV daily or even higher doses up to 500 mg three times daily for encephalopathy of uncertain etiology 1
- The FDA label supports doses of 25 mg IV cautiously in infantile beriberi with collapse 6, though recent evidence and expert consensus favor higher doses (100-200 mg) regardless of age given the safety profile 5
For Mild-Moderate Deficiency (outpatient, stable):
- 10 mg/day orally for one week, followed by 3-5 mg daily for at least 6 weeks 1
- Maintenance after acute treatment: 50-100 mg/day orally 1
For Parenteral Nutrition (PN) in Children:
- Infants <12 months: 0.35-0.50 mg/kg/day 3
- Children >12 months: 1.2 mg/day 3
- These are maintenance doses; deficiency requires therapeutic dosing as above
Route of Administration
Use IV route for:
- Any acute presentation or suspected deficiency
- Encephalopathy, cardiac symptoms, or lactic acidosis
- Hospitalized patients with reduced intake or high metabolic demands
- When absorption is questionable (though thiamine is well-absorbed orally except in alcohol-related gastritis) 1
Oral route acceptable for:
- Mild deficiency in stable outpatients
- Maintenance therapy after acute treatment
- Prevention in at-risk populations
Critical Clinical Pitfalls
Always give thiamine BEFORE glucose administration in at-risk patients to prevent precipitating Wernicke's encephalopathy or Korsakoff syndrome 6, 5. Give 100 mg thiamine in the first few liters of IV dextrose 6.
Do not wait for laboratory confirmation - treat immediately on clinical suspicion. Erythrocyte transketolase activity (TPPE >15% indicates deficiency, >25% severe deficiency) or whole blood thiamine diphosphate (ThDP) are diagnostic but results take time 1, 4.
High index of suspicion needed for:
- Exclusively/predominantly breastfed infants (especially if maternal deficiency) 2
- Children with vomiting, lethargy, hoarse voice/loss of voice, cyanosis, poor eye contact 2
- Cardiac disease patients on chronic diuretics 7
- Post-bariatric surgery patients
- Refeeding syndrome risk (give 300 mg IV before initiating nutrition) 1
Neurologic symptoms may be subtle initially - ophthalmoplegia, nystagmus, ataxia, or simply lethargy and irritability 4. The classic triad of Wernicke's is often incomplete in children.
Duration of Treatment
- Acute phase: minimum 3-4 days IV for suspected deficiency 1, 2
- Continue until clinical improvement - neurologic symptoms may improve within hours to days 4
- Transition to oral maintenance (50-100 mg daily) for at least 6 weeks after acute treatment 1
- Long-term supplementation needed if underlying risk factors persist
Safety Profile
Thiamine is remarkably safe with no established upper limit 1. Doses of 100-500 mg are well-tolerated 6. Rare anaphylaxis with high IV doses has been reported but is extremely uncommon 1. The risk of under-treatment far exceeds any toxicity concerns, particularly in children where deficiency can be rapidly fatal 3, 4.
Special Populations
Infants with suspected deficiency from defective formula or maternal deficiency:
- 50 mg IM daily for 14 days was effective in the Israeli outbreak 4
- However, given current evidence, 100 mg IV daily is reasonable even in young infants 2, 5
Critical illness/ICU patients:
- 100-300 mg/day IV from admission 1
- Higher metabolic demands and inflammation increase requirements
Continuous renal replacement therapy:
- 100 mg/day to replace losses 1